Vaping, JUUL and E-Cigarettes: A Public Health Crisis James Latronica, D.O. Anthony Dekker, D.O. American Osteopathic Association of Addiction Medicine
Disclosure • Neither presenter has any conflicts of interest or disclosures to address
JUUL is not alone…
What’s In a JUUL Pod?
Lung Injury
Lung Injury
E-Cigarettes As Smoking Cessation
The “Harm Reduction” Aspect
SUD and Tobacco
SUD and Tobacco
Profit Incentive • Juul • $1.2 Billion sales (Jan – Jun 2019) • 2016-- 2.2 million units • 2017-- 16.2 million units
Profit Incentive • James Monsees (39) and Adam Bowen (44) • Stanford University -- smoke break 2005 • Cessation? • Ploom 2007 • Pax Labs cannabis
Tobacco Advertising
Tobacco Advertising
Point of Care Actions S creening B rief I ntervention R eferral T reatment
• Risa Turetsky, MPH, FNP-C, PHN
Resources • https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html • Hajek P, Phillips-Waller A, Przulj D, et al. A randomized trial of e-cigarettes versus nicotine- replacement therapy. N Engl J Med . 2019;380(7):629-637. doi:10.1056/NEJMoa1808779 • Changing Perceptions of Harm of e-Cigarette vs Cigarette Use Among Adults in 2 US National Surveys From 2012 to 2017; Jidong Huang, PhD 1 ; Bo Feng, PhD 2,3 ; Scott R. Weaver, PhD 4 ; et al • National Survey on Drug Use and Health (2016) – accessed via samhsa.gov • Remainder of sources are cited on the slides themselves
Recommend
More recommend